Evidence that the novel antihypertensive agent, flesinoxan, causes differential sympathoinhibition and also increases vagal tone by a central action

European Journal of Pharmacology
A G RamageP Bevan

Abstract

The effects of flesinoxan were studied on thoracic preganglionic, splanchnic and renal sympathetic nerve activity, carotid sinus nerve activity, blood pressure and heart rate in anaesthetised cats. In some experiments femoral or renal arterial conductance was also recorded. Flesinoxan (3-300 micrograms kg-1) caused a dose-related fall in blood pressure and heart rate and also caused sympathoinhibition. This fall in blood pressure was not associated with changes in femoral arterial conductance but was with a large increase in renal arterial conductance. In this respect flesinoxan had a greater sympathoinhibitory action on the renal nerve compared with the other sympathetic outflows. The bradycardia was unaffected by the 5-HT3 antagonist, MDL 72222, but was reversed by atropine and was abolished in bi-vagotomised cats. Flesinoxan also caused sympathoinhibition in bi-vagotomised cats and decreased carotid sinus nerve activity and blood pressure. It is concluded that flesinoxan acts centrally to cause sympathoinhibition and an increase in vagal tone.

Citations

May 31, 1990·European Journal of Pharmacology·R Bouhelal, A K Mir
Sep 21, 1990·European Journal of Pharmacology·S L ShepheardA G Ramage
Aug 6, 1991·European Journal of Pharmacology·S AhleniusA Wijkström
Nov 17, 1992·European Journal of Pharmacology·S Buisson-Defferier, M Van den Buuse
Jan 1, 1993·Brain Research. Brain Research Reviews·F Chaouloff
Jan 16, 2002·European Journal of Pharmacology·Ruben D BuñagJennifer R Mellick
Dec 26, 2001·Brain Research Bulletin·A G Ramage
Apr 1, 1999·Journal of Pharmacological and Toxicological Methods·A M DeveneyD M Jackson
Aug 1, 1990·British Journal of Pharmacology·R G BogleA G Ramage
Jan 1, 1992·British Journal of Pharmacology·R Bouhelal, A K Mir
May 1, 1994·British Journal of Pharmacology·A L Chamienia, E J Johns
Apr 1, 1990·The Journal of Pharmacy and Pharmacology·S AhleniusA Wijkström
Oct 1, 2003·British Journal of Pharmacology·P JanssenR A Lefebvre
Aug 15, 1989·The American Journal of Cardiology·N KolassaK H Sanders
Jan 1, 1989·Fundamental & Clinical Pharmacology·P R Saxena
Jan 1, 1991·Journal of Receptor Research·A A HancockJ F DeBernardis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.